Inhibrx Biosciences, Inc. (INBX)

82.21 -2.30 (-2.72%) USD  |  NASDAQ  |  Dec 11, 16:00
82.18 -0.03 (-0.04%) Pre-Market: 08:44
More

Inhibrx Biosciences EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for INBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Agenus, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Pelthos Therapeutics, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade